Your browser doesn't support javascript.
loading
Clinical development and evaluation of a VEGF-D assay in plasma from patients with metastatic colorectal cancer in the RAISE study.
Taniguchi, Hiroya; Yoshino, Takayuki; Yamaguchi, Kensei; Yamazaki, Kentaro; Nixon, Andrew B; Tabernero, Josep; Van Cutsem, Eric; Robling, Kim R; Abada, Paolo B; Hozak, Rebecca R; Siegel, Robert; Fill, Jeffrey A; Wijayawardana, Sameera; Walgren, Richard A; Giles, Brendan; Jones, Abby; Pitts, Kelly R; Drove, Nora; Muro, Kei.
Afiliación
  • Taniguchi H; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yoshino T; Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Yamaguchi K; Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East, Kashiwa, Japan.
  • Yamazaki K; Department of Gastroenterological Chemotherapy, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan.
  • Nixon AB; Division of Gastrointestinal Oncology, Shizuoka Cancer Center, Shunt-gun, Japan.
  • Tabernero J; Department of Medicine, Duke University School of Medicine, Durham, NC, USA.
  • Van Cutsem E; Medical Oncology Department, Vall d'Hebron University Hospital and Institute of Oncology (VHIO), IOB-Quiron, UVic-UCC, Barcelona, Spain.
  • Robling KR; Digestive Oncology, University Hospitals Leuven and Kuleuven, Leuven, Belgium.
  • Abada PB; Clinical Diagnostics Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
  • Hozak RR; Oncology Division, Eli Lilly and Company, Indianapolis, IN, USA.
  • Siegel R; Oncology Business Unit - Patient Tailoring & Global Strategic Planning, Eli Lilly and Company, Indianapolis, IN, USA.
  • Fill JA; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, USA.
  • Wijayawardana S; Clinical Diagnostics Laboratory, Eli Lilly and Company, Indianapolis, IN, USA.
  • Walgren RA; Statistics - Oncology, Eli Lilly and Company, Indianapolis, IN, USA.
  • Giles B; Oncology Division, Eli Lilly and Company, Indianapolis, IN, USA.
  • Jones A; Corgenix Inc., Broomfield, CO, USA.
  • Pitts KR; Corgenix Inc., Broomfield, CO, USA.
  • Drove N; Corgenix Inc., Broomfield, CO, USA.
  • Muro K; Oncology Division, Eli Lilly and Company, Indianapolis, IN, USA.
Curr Med Res Opin ; 37(10): 1769-1778, 2021 10.
Article en En | MEDLINE | ID: mdl-34229554
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Curr Med Res Opin Año: 2021 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Colorrectales / Neoplasias del Colon Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Humans Idioma: En Revista: Curr Med Res Opin Año: 2021 Tipo del documento: Article País de afiliación: Japón